Transcat, Inc. (NasdaqGM:TRNS) will look for acquisitions. Lee Rudow, President and CEO said " Our integration process enables new acquisitions such as the recent deal with Axiom to very quickly be accretive to the overall company. We ended the third quarter well positioned financially with strong operating cash flow generation and balance sheet capacity, both of which allow us to actively pursue the M&A opportunities that comprise our current robust acquisition pipeline".
"We believe the Service segment has a substantial runway ahead for growth both organically and through acquisition. Our active and diverse acquisition pipeline enables strategic accretive acquisitions that drive synergistic growth opportunities and will be a key component of our go-forward strategy".
Transcat, Inc. is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, computerized maintenance management system (CMMS), and pipette services. The Company is focused on providing services and products to regulated industries, particularly the life science industry, which includes pharmaceutical, biotechnology, medical device, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. Its Service segment offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting and other related services, a majority of which are processed through its asset management system, CalTrak and its online customer portal, C3. Its Distribution segment sells and rents national and brand instruments to customers globally. It provides periodic on-site services, mobile calibration services, pickup and delivery, in-house services at its 27 calibration service centers.
TRANSCAT, INC. 
